In September 2025, Chiundo Co., Ltd. announced the official signing of a GMP consulting contract with a Lao pharmaceutical company, marking the start of a long-term strategic partnership. Under this agreement, Chiundo will provide full-process consulting services to support the planning, construction, and certification of a modern pharmaceutical factory that meets international standards, positioning the project as a new industry benchmark in Laos.

Background: A New Stage for Laos’ Pharmaceutical Industry

With growing public health needs across Southeast Asia, the Lao pharmaceutical industry is entering a critical phase of upgrading. Pharmaceutical capabilities not only impact the safety of medicines for domestic populations but also determine a country’s position within regional healthcare markets.

However, the development of GMP-compliant factories is a capital-intensive, technically complex, and time-consuming process. It requires systematic planning across multiple stages, including site selection, facility design, equipment procurement, quality system establishment, regulatory compliance, and international certification.

Against this backdrop, the Lao pharmaceutical company sought to collaborate with Chiundo, a Japan-based firm with a strong track record in GMP consulting, compliance management, and international project execution. This cooperation aims to accelerate the development of a factory that meets international standards and strengthens Laos’ pharmaceutical industry capacity.

Chiundo’s Role: Comprehensive GMP Consulting Support

According to the contract, Chiundo will provide end-to-end GMP consulting services, covering:

Site Planning and Assessment: Supporting site selection to ensure compliance with environmental, logistics, and regulatory requirements.

Facility Design and Equipment Selection: Introducing Japan’s advanced GMP concepts while aligning with international standards to create tailored layouts and equipment strategies for the Lao facility.

Quality Systems and Software Integration: Assisting in the adoption of LIMS (Laboratory Information Management Systems), ERP, and other quality and traceability platforms to meet international audit expectations.

Laboratory Setup and Pilot Validation: Establishing microbiology labs, stability testing centers, and quality control labs, while guiding clients through pilot production and validation processes to accelerate certification.

Talent Training and Knowledge Transfer: Providing on-site training and remote support to build a capable local team that can operate under GMP standards, ensuring long-term sustainability.

Strategic Significance: Setting a Benchmark for Laos

The implementation of this project goes beyond corporate collaboration—it represents a milestone in the modernization of Laos’ pharmaceutical sector. The factory, once completed, will serve as a benchmark in several ways:

Improving Public Health Capacity: Enhancing domestic pharmaceutical production to ensure safe and reliable medicine for the Lao people.

Promoting International Cooperation: Establishing internationally compliant production capacity to integrate Lao pharmaceutical companies into regional and global supply chains.

Driving Industry Upgrades: Providing Laos with valuable experience in GMP compliance, while attracting foreign investment and partnerships.

Strengthening Brand Reputation: Building a flagship facility will enhance the credibility of Lao pharmaceutical companies in international markets, supporting expansion into Southeast Asia and beyond.

Chiundo’s Commitment: Professionalism, Efficiency, and Compliance

Chiundo Co., Ltd. has long been active in the pharmaceutical and healthcare industries in Japan, holding a Pharmaceutical Wholesale License issued by the Japanese government. The company has also successfully executed international GMP consulting projects in India, Bangladesh, and Laos. Guided by its core values of “Professionalism, Efficiency, and Compliance,” Chiundo is committed to delivering comprehensive solutions that help clients overcome compliance challenges and succeed in international competition.

Outlook: Building a New Chapter in Pharmaceutical Development

This partnership with the Lao pharmaceutical company represents another significant step in Chiundo’s international strategy. Moving forward, the company will continue to leverage its expertise in resource integration and cross-border services to help more emerging-market countries strengthen their pharmaceutical industries and align with international standards.

Chiundo firmly believes that the successful implementation of this project will establish not only a flagship factory for Laos but also a model of pharmaceutical cooperation in Southeast Asia. Together with its partners, the company looks forward to shaping a new chapter in the development of the pharmaceutical and healthcare industries.